Skip to content

Clinical trials

Completed Lung Neoplasms trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Not applicable Status: Completed Clear all

606 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20035
200412
20057
200617
200711
200815
200920
201018
201121
201219
201321
201425
201540
201636
201738
201842
201927
202042
202148
202234
202341
202432
202516
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed606

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center12
Massachusetts General Hospital12
City of Hope Medical Center11
Centre hospitalier de l'Université de Montréal (CHUM)10
Memorial Sloan Kettering Cancer Center9
University Health Network, Toronto8
Abramson Cancer Center at Penn Medicine7
VA Office of Research and Development7
Wake Forest University Health Sciences7
Duke University6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms606
Carcinoma, Non-Small-Cell Lung88
Breast Neoplasms70
Prostatic Neoplasms41
Neoplasms39
Colorectal Neoplasms37
Head and Neck Neoplasms34
Colonic Neoplasms22
Small Cell Lung Carcinoma21
Esophageal Neoplasms18

Trials

Showing 1 to 25 of 606. Each trial links to its page on Pharma Observatory.

506 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.